{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:58:36Z","timestamp":1781650716172,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background. Cytokine release syndrome (CRS) is the most frequent toxicity after chimeric antigen receptor T-cell (CAR-T) therapy and typically presents as a systemic inflammatory syndrome. In recent years, a localized form of CRS (L-CRS), most commonly involving the craniocervical region, has been increasingly recognized. L-CRS may occur with or without overt local tumor involvement and can progress to airway impairment, requiring prompt recognition and treatment. Case presentation. We report two cases of patients with refractory diffuse large B-cell lymphoma (DLBCL) treated with anti-CD19 CAR-T therapy who developed abrupt, painful bilateral parotid and\/or submandibular gland swelling (left predominance) early after infusion, following systemic CRS treated with tocilizumab. Infectious, obstructive, and autoimmune causes were excluded; ultrasound findings were compatible with inflammatory glandular changes. Given rapid progression and concern for airway patency, corticosteroids were administered with prompt clinical resolution. Literature review and diagnostic alert. We provide an overview of published L-CRS with craniocervical presentations (Table 1). Similar acute swelling temporally related to tocilizumab has been reported in other settings. In such cases, differential diagnostics of L-CRS vs. a tocilizumab-associated infusion-related\/hypersensitivity reaction needs to be carried out. Conclusion. L-CRS is a clinically relevant and potentially severe complication of CAR-T therapy that may involve salivary glands even without cervical tumor burden. Clinicians should also consider drug-related reactions, particularly when cervical swelling occurs shortly after tocilizumab administration.<\/jats:p>","DOI":"10.1007\/s00277-026-07013-0","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:34:49Z","timestamp":1776814489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Organ-specific local cytokine release syndrome after anti-CD19 CAR-T therapy with salivary gland involvement: a case report, literature review, and a diagnostic alert for tocilizumab-associated cervical swelling"],"prefix":"10.1007","volume":"105","author":[{"given":"Roberto","family":"Maggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Federico","family":"Ricciuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Sor\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Fiorita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Chiusolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"3","key":"7013_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","volume":"33","author":"PJ Hayden","year":"2022","unstructured":"Hayden PJ et al (2022) Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the european society for blood and marrow transplantation (EBMT) and the joint accreditation committee of ISCT and EBMT (JACIE) and the European haematology association (EHA). Ann Oncol 33(3):259\u2013275. https:\/\/doi.org\/10.1016\/j.annonc.2021.12.003","journal-title":"Ann Oncol"},{"issue":"2","key":"7013_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12185-022-03373-0","volume":"116","author":"S Kawase","year":"2022","unstructured":"Kawase S, Sakurai M, Masuda K et al (2022) Salivary gland swelling as a characteristic manifestation of local cytokine release syndrome after anti-CD19 chimeric antigen receptor T-cell therapy: a case series. Int J Hematol 116(2):289\u2013295. https:\/\/doi.org\/10.1007\/s12185-022-03373-0","journal-title":"Int J Hematol"},{"issue":"6","key":"7013_CR3","doi-asserted-by":"publisher","first-page":"e424","DOI":"10.1016\/S2665-9913(25)00091-8","volume":"7","author":"M Hagen","year":"2025","unstructured":"Hagen M, M\u00fcller F, Wirsching A et al (2025) Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study. Lancet Rheumatol 7(6):e424\u2013e433. https:\/\/doi.org\/10.1016\/S2665-9913(25)00091-8","journal-title":"Lancet Rheumatol"},{"key":"7013_CR4","doi-asserted-by":"publisher","first-page":"707191","DOI":"10.3389\/fimmu.2021.707191","volume":"12","author":"C Luan","year":"2021","unstructured":"Luan C, Zhou J, Wang H et al (2021) Local cytokine release syndrome in an acute lymphoblastic leukemia patient after treatment with chimeric antigen receptor T-cell therapy: a possible model, literature review and perspective. Front Immunol 12:707191. https:\/\/doi.org\/10.3389\/fimmu.2021.707191","journal-title":"Front Immunol"},{"issue":"1","key":"7013_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41392-020-00256-x","volume":"5","author":"J Wei","year":"2020","unstructured":"Wei J, Liu Y, Wang C et al (2020) The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-hodgkin lymphoma. Signal Transduct Target Ther 5(1):134. https:\/\/doi.org\/10.1038\/s41392-020-00256-x","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"7013_CR6","doi-asserted-by":"publisher","first-page":"rkab072","DOI":"10.1093\/rap\/rkab072","volume":"5","author":"C Baenziger-Sieber","year":"2021","unstructured":"Baenziger-Sieber C, Aschwanden M, Jaeger VK et al (2021) Throat swelling following tocilizumab infusion\u2014not always angioedema. Rheumatol Adv Pract 5(3):rkab072. https:\/\/doi.org\/10.1093\/rap\/rkab072","journal-title":"Rheumatol Adv Pract"},{"issue":"1","key":"7013_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00296-019-04457-3","volume":"40","author":"SJ Park","year":"2020","unstructured":"Park SJ, Lee J, Park YB et al (2020) Tocilizumab-induced anaphylaxis in adult-onset still\u2019s disease and systemic juvenile idiopathic arthritis: a case series. Rheumatol Int 40(1):159\u2013163. https:\/\/doi.org\/10.1007\/s00296-019-04457-3","journal-title":"Rheumatol Int"},{"key":"7013_CR8","doi-asserted-by":"publisher","first-page":"2050313X2210798","DOI":"10.1177\/2050313X221079889","volume":"10","author":"DS Villacis-Nunez","year":"2022","unstructured":"Villacis-Nunez DS, Jones SM, Chiarella SE (2022) Immediate and delayed hypersensitivity reactions to biologics: an updated review of the literature. SAGE Open Med Case Rep 10:2050313X221079889. https:\/\/doi.org\/10.1177\/2050313X221079889","journal-title":"SAGE Open Med Case Rep"},{"issue":"4","key":"7013_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL et al (2019) ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transpl 25(4):625\u2013638. https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.758","journal-title":"Biol Blood Marrow Transpl"},{"key":"7013_CR10","doi-asserted-by":"publisher","first-page":"e38905","DOI":"10.7759\/cureus.38905","volume":"15","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Fujino T, Chinen S et al (2023) Cervical local cytokine release syndrome following chimeric antigen receptor T-cell therapy in patients with relapsed or refractory diffuse large B-cell lymphoma. Cureus 15:e38905. https:\/\/doi.org\/10.7759\/cureus.38905","journal-title":"Cureus"},{"key":"7013_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3348\/kjr.2023.1100","volume":"25","author":"JS Ko","year":"2024","unstructured":"Ko JS, Lee JH, Yoon DH et al (2024) CT demonstration of local cytokine-release syndrome involving the head and neck following chimeric antigen receptor T cell infusion therapy. Korean J Radiol 25:399\u2013402. https:\/\/doi.org\/10.3348\/kjr.2023.1100","journal-title":"Korean J Radiol"},{"key":"7013_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12185-023-03633-8","volume":"118","author":"Y Nakanishi","year":"2023","unstructured":"Nakanishi Y, Marumo Y, Ri M et al (2023) Laryngeal edema as a symptom of local cytokine release syndrome after BCMA-targeting CAR-T therapy for relapsed and refractory multiple myeloma. Int J Hematol 118:647\u2013651. https:\/\/doi.org\/10.1007\/s12185-023-03633-8","journal-title":"Int J Hematol"},{"key":"7013_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000522669","volume":"15","author":"H Shima","year":"2022","unstructured":"Shima H, Kurosawa T, Oikawa H et al (2022) Cervical edema extending to the larynx as local cytokine release syndrome following chimeric antigen receptor T-cell therapy in a boy with refractory acute lymphoblastic leukemia. Case Rep Oncol 15:257\u2013262. https:\/\/doi.org\/10.1159\/000522669","journal-title":"Case Rep Oncol"},{"key":"7013_CR14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41409-018-0398-6","volume":"54","author":"A Jin","year":"2019","unstructured":"Jin A, Feng J, Wang Z et al (2019) Severe dyspnea caused by rapid enlargement of cervical lymph node in a relapsed\/refractory B-cell lymphoma patient following chimeric antigen receptor T-cell therapy. Bone Marrow Transpl 54:969\u2013972. https:\/\/doi.org\/10.1038\/s41409-018-0398-6","journal-title":"Bone Marrow Transpl"},{"key":"7013_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/omcr\/omae164","volume":"1","author":"N Nakamura","year":"2025","unstructured":"Nakamura N, Jo T, Arai Y et al (2025) Severe cases of local cytokine release syndrome (CRS); craniocervical edema soon after chimeric antigen receptor T-cell (CAR-T) therapy. Oxf Med Case Rep 1:9\u201311. https:\/\/doi.org\/10.1093\/omcr\/omae164","journal-title":"Oxf Med Case Rep"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07013-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07013-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07013-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:31:06Z","timestamp":1781649066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07013-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["7013"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07013-0","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Helsinki Declaration and was approved by the local ethics committee (ID 4879 Prot 0020777\/22 Amendment 09\/2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Written informed consent for publication of clinical details and images was obtained from both patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}